Metformin HCl 是一种双胍类降糖药,用于治疗对饮食调整没有反应的非胰岛素依赖型糖尿病。
Metformin HCl is one of the most effective and widely used therapeutics for treatment of type 2 diabetes. It selectively lowers the hepatic gluconeogenesis without rising insulin production, causing weight gain or hypoglycemia.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Zhou G, et al. J Clin Invest, 2001, 108(8), 1167-1174.
分子式 C4H11N5.HCl |
分子量 165.62 |
CAS号 1115-70-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 33 mg/mL |
Water 33 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00187798 | Other Conditions That May Be A Focus of Clinical Attention | Drug: Metformin HCl | University of California, San Francisco | 2001-08-01 | 2012-09-24 | |
NCT02978547 | Resectable Pancreatic Ductal Adenocarcinoma | Drug: Metformin Hydrochloride 500Mg Tablet | British Columbia Cancer Agency|Pancreatic Cancer Canada|BC Cancer Foundation | Phase 2 | 2017-01-01 | 2016-11-28 |
NCT02670018 | Healthy | Drug: gemigliptin and metformin HCl extended release|Drug: gemigliptin/metformin HCl extended release | LG Life Sciences | Phase 1 | 2015-08-01 | 2016-01-31 |
NCT01595880 | Healthy | Drug: gemigliptin and metformin HCl extended release|Drug: gemigliptin/metformin HCl extended release | LG Life Sciences | Phase 1 | 2014-12-01 | 2015-02-02 |
NCT01662674 | Healthy | Drug: gemigliptin and metformin HCl extended release|Drug: gemigliptin/metformin HCl extended release | LG Life Sciences | Phase 1 | 2012-10-01 | 2015-04-02 |
NCT02056600 | Healthy | Drug: gemigliptin and metformin HCl extended release|Drug: gemigliptin/metformin HCl sustained release | LG Life Sciences | Phase 1 | 2014-03-01 | 2014-05-07 |
NCT02972723 | Chronic Hepatitis C Infection | Drug: Metformin | Nottingham University Hospitals NHS Trust | Phase 4 | 2011-03-01 | 2016-11-22 |
NCT02684578 | Age-Related Macular Degeneration|Macular Degeneration, Age-Related|Dry Macular Degeneration|Geographic Atrophy | Drug: Metformin | University of California, San Francisco|Northwestern University|University of California, Irvine|University of California, Davis|San Francisco Veterans Affairs Medical Center|Retinal Consultants of Arizona | Phase 2 | 2016-04-01 | 2017-02-02 |
NCT01357148 | Diabetes Mellitus, Type 2 | Drug: Sitagliptin Phosphate/Metformin HCl (JANUMET) | Merck Sharp & Dohme Corp. | 2009-03-01 | 2015-08-07 | |
NCT00865072 | Healthy | Drug: Metformin HCl 750 mg Extender Release tablets, single dose|Drug: GLUCOPHAGE XR 750 mg tablets, single dose | Actavis Inc. | Phase 1 | 2003-08-01 | 2010-08-13 |
NCT00865852 | Healthy | Drug: Metformin HCl 750 mg Extender Release tablets, single dose|Drug: GLUCOPHAGE XR 750 mg tablets, single dose | Actavis Inc. | Phase 1 | 2003-08-01 | 2010-08-13 |
NCT01997775 | Non-small Cell Lung Cancer | Drug: METFORMIN | National Cheng-Kung University Hospital | Phase 2 | 2013-08-01 | 2016-09-29 |
NCT02086526 | Polycystic Ovary Syndrome | Drug: Metformin | Mayo Clinic | Phase 1|Phase 2 | 2014-03-01 | 2016-05-19 |
NCT02496741 | Glioma|Cholangiocarcinoma|Chondrosarcoma | Drug: Metformin and chloroquine combination | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1|Phase 2 | 2015-11-01 | 2015-11-14 |
NCT01486043 | Acute Lymphoblastic Leukemia|Hyperglycemia|Insulin Resistance|Diabetes Mellitus | Drug: Metformin | Children's Hospital Los Angeles | 2011-12-01 | 2015-01-20 | |
NCT01747083 | Type 2 Diabetes | Drug: FDC(gemigliptin/metformin HCl sustained release 50/1000mg(25/500mg x 2tablets)) | LG Life Sciences | Phase 1 | 2013-01-01 | 2013-10-22 |
NCT00570739 | Type 2 Diabetes Mellitus|Hypercholesterolemia|Pre-diabetes | Drug: Metformin HCl and Colesevelam Placebo|Drug: Metformin HCl tablets and Colesevelam tablets|Drug: Colesevelam placebo|Drug: Colesevelam | Daiichi Sankyo Inc. | Phase 3 | 2007-11-01 | 2010-07-19 |
NCT01266486 | Breast Cancer | Drug: Metformin | Oxford University Hospitals NHS Trust|Cancer Research UK | Phase 2 | 2011-05-01 | 2014-07-01 |
NCT02354027 | Type 2 Diabetes | Drug: SHR3824 metformin | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 | 2014-09-01 | 2015-07-14 |
NCT00865748 | Healthy | Drug: Metformin HCl 500 mg tablets, single dose|Drug: CLUCOPHAGEXR 500 mg tablets, single dose | Actavis Inc. | Phase 1 | 2004-01-01 | 2010-08-13 |
NCT00865839 | Healthy | Drug: Metformin HCl 500 mg tablets, single dose|Drug: CLUCOPHAGEXR 500 mg tablets, single dose | Actavis Inc. | Phase 1 | 2002-03-01 | 2010-08-13 |
NCT00864669 | Healthy | Drug: Metformin HCl 500 mg tablets, single dose|Drug: CLUCOPHAGEXR 500 mg tablets, single dose | Actavis Inc. | Phase 1 | 2002-03-01 | 2010-08-13 |
NCT01873859 | Diabetes Mellitus|Lactic Acidosis | Drug: Metformin | Shahid Beheshti University of Medical Sciences | 2013-05-01 | 2014-05-16 | |
NCT03086005 | Polycystic Ovary Syndrome | Drug: Metformin | Chung-Hoon Kim|Asan Medical Center | 2011-10-12 | 2017-03-15 | |
NCT03017833 | Solid Tumor|Advanced Cancer | Drug: Metformin|Drug: TAK-228 | M.D. Anderson Cancer Center|Takeda Pharmaceuticals International, Inc. | Phase 1 | 2017-06-01 | 2017-03-17 |
NCT01409395 | Healthy | Drug: Metformin and nizatidine|Drug: Metformin | University of California, San Francisco|National Institute of General Medical Sciences (NIGMS) | Phase 1 | 2011-09-01 | 2014-04-09 |
NCT01884558 | Pharmacokinetics of Isavuconazole|Pharmacokinetics of Metformin|Healthy Subjects | Drug: isavuconazole|Drug: metformin | Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd|Astellas Pharma Inc | Phase 1 | 2013-02-01 | 2013-06-20 |
NCT01561482 | Prostate Carcinoma | Drug: Metformin|Drug: Simvastatin | Nicholas Mitsiades|Baylor College of Medicine | Phase 2 | 2012-01-01 | 2015-07-20 |
NCT02895750 | Renal Insufficiency, Chronic | Drug: Metformin | Centre Hospitalier Universitaire, Amiens | Phase 2 | 2016-09-01 | 2016-09-06 |
NCT01681680 | Healthy | Drug: Metformin | University of California, San Francisco | Phase 1 | 2010-10-01 | 2014-06-30 |
NCT01422746 | Obesity|Hyperandrogenemia|Polycystic Ovary Syndrome | Drug: Metformin | University of Virginia | 2016-12-01 | 2016-12-16 | |
NCT01334684 | Type 2 Diabetes | Drug: Metformin | Casa Sollievo della Sofferenza IRCCS|University Hospital, Catania | 2011-05-01 | 2011-04-12 | |
NCT01613755 | Diabetes | Drug: Metformin, dipyridamole|Drug: Metformin | Radboud University | Phase 4 | 2012-04-01 | 2013-04-26 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们